Priority Date: 29.09.11 (US 201161540618P)

MUTATIONS IN SF3B1 AND CHRONIC LYMPHOCYTIC LEUKEMIA

  • Application ID: EP12775575
  • Status: PATENT GRANTED

Attorney

no operation time available
1141.11
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) and G01 (MEASURING; TESTING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Weidner Stern Jeschke, Zacco Denmark A/S and 92 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 29.09.2011 - Priority Date (US 201161540618P)
  • 04.04.2013 - Publication A1 (WO2013049750)
  • 06.08.2014 - Publication A1 (EP2761299)
  • 26.10.2016 - Publication B1 (EP2761299)

IPC Classification